EMEA-000828-PIP04-16-M01

Key facts

Invented name
Jardiance
Active substance
empagliflozin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0165/2018
PIP number
EMEA-000828-PIP04-16-M01
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate formulation
Condition(s) / indication(s)
Treatment of type 1 diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH

Tel. +49 6132778271
E-mail: paediatrics@boehringer-ingelheim.com

 

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating